Last reviewed · How we verify
NCT07525908
Efficacy of a Self-Efficacy Nursing Model in CyberKnife-Treated Lung Cancer Patients
NA trial testing Self-Efficacy Theory-Based Nursing Model in Lung Neoplasms in 300 participants. Completed in 31 October 2024.
31 October 2024
Quick facts
| Lead sponsor | The First Hospital of Hebei Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 300 |
| Start date | 1 October 2023 |
| Primary completion | 31 October 2024 |
| Estimated completion | 31 October 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Self-Efficacy Theory-Based Nursing Model
- Routine Nursing Care
Conditions studied
- Lung Neoplasms — all drugs for Lung Neoplasms →
- Anxiety — all drugs for Anxiety →
Sponsor
The First Hospital of Hebei Medical University
Who can join
Adults 40 to 80, any sex, with Lung Neoplasms or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates whether a multi-component nursing model based on self-efficacy theory can alleviate psychological distress, mitigate pain, and improve the quality of life (QoL) in lung cancer patients undergoing CyberKnife stereotactic radiosurgery compared to routine nursing care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07525908
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung Neoplasms
Currently open trials in the same condition.
- NCT07476287 — Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult · Phase 2 · recruiting
- NCT07509333 — MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients · NA · recruiting
- NCT07109154 — DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First- · recruiting
- NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting
- NCT07165691 — TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics · NA · recruiting
Other The First Hospital of Hebei Medical University trials
Trials by the same sponsor.
- NCT07467603 — ED50 of Remimazolam for Anesthesia Induction in Frail Elderly Patients · NA · completed
- NCT07243444 — Home-Based Versus Center-Based Cardiac Rehabilitation After CABG Surgery · NA · completed
- NCT07232693 — Telerehabilitation vs. Center-Based Rehab for Psychological Well-being After CABG · NA · completed
- NCT07047534 — EEG-Triggered rTMS and Group Therapy for Adolescents With Depression and Self-Harm · NA · completed
- NCT06344390 — Effect of Pentoxifylline on Cognitive Impairment After Ischemic Stroke · Phase 1, PHASE2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07525908 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Hospital of Hebei Medical University
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07525908.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing